HIV-Protease Inhibitors | NEJM
The bitter Asteraceae: An interesting approach to delay the metabolic syndrome progression - ScienceDirect
Supersaturable self-microemulsifying delivery systems: an approach to enhance oral bioavailability of benzimidazole anticancer drugs | SpringerLink
Frontiers | Advances in Oral Drug Delivery | Pharmacology
50 years of oral lipid-based formulations: Provenance, progress and future perspectives - ScienceDirect
Molecules | Free Full-Text | Marine Natural Products as Models to Circumvent Multidrug Resistance | HTML
Frontiers | HIV Diagnosis and Treatment through Advanced Technologies | Public Health
Pharmaceutics | Free Full-Text | Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems | HTML
NOVEL APPROACHES FOR DEVELOPMENT AND CHARACTERIZATION OF SMEDDS: REVIEW | Semantic Scholar
The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets - Document - Gale Academic OneFile
Roman FAQ - Men's Health, ED, Telehealth, Costs, & More | Roman
Publications | mysite
Polypeptide-based drug delivery systems for programmed release - ScienceDirect
Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers - ScienceDirect
HIV-Protease Inhibitors | NEJM
Strategies to Formulate Lipid-based Drug Delivery Systems | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
A Review on Novel Therapeutic Strategies for the Enhancement of Solubility for Hydrophobic Drugs through Lipid and Surfactant Based Self Micro Emulsifying Drug Delivery System: A Novel Approach - SciAlert Responsive Version
Pharmacokinetic Parameters of HIV‐1 Protease Inhibitors - Nascimento - 2020 - ChemMedChem - Wiley Online Library
Nomenclature of commonly used/commercially available antiviral... | Download Table
Full article: Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2
HIV-Protease Inhibitors | NEJM
HIV-Protease Inhibitors | NEJM
Viruses | Free Full-Text | Current and Novel Inhibitors of HIV Protease | HTML
HIV Therapy—The State of ART | SpringerLink
Current and Novel Inhibitors of HIV Protease. - Abstract - Europe PMC
